CDMO / Manufacturing

Scale-Up in Peptide Manufacturing: From Lab to Multi-Ton Production

← Back to Guides

Scaling up peptide synthesis from laboratory to multi-ton production presents significant technical challenges that require careful planning and expertise. The global CDMO Service for Peptide APIs market is projected to grow from US$ 3,986 million in 2025 to US$ 13,186 million by 2032[reference:138], driving demand for scale-up capabilities.

Key challenges in scale-up include heat transfer and mixing efficiency, which affect reaction kinetics and product quality. At larger scales, heat generated by exothermic reactions must be effectively removed to prevent temperature excursions. Mixing must be sufficient to ensure homogeneity of reagents and efficient mass transfer. These factors require careful reactor design and process optimization.

Impurity profiles may change during scale-up due to differences in reaction conditions. Impurities that are minor at small scale may become significant at larger scale, requiring additional purification. Process development must identify critical process parameters and define their acceptable ranges to ensure consistent product quality.

Purification scale-up presents additional challenges. Preparative HPLC columns must be scaled appropriately, with consideration of column diameter, flow rate, and gradient conditions. Lyophilization must be scaled to handle larger batches while maintaining product quality. Each step must be validated to demonstrate consistent performance.

Solutions to scale-up challenges include use of design of experiments (DoE) to define robust operating ranges, process modeling to predict behavior at larger scales, and scale-down studies to rapidly optimize conditions using smaller quantities of material. At PeptideHub, we have extensive experience in peptide synthesis scale-up, with facilities supporting production from grams to >100kg.